Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide injection in rats.

作者: Charleine Zussy , Anthony Brureau , Emeline Keller , Stéphane Marchal , Claire Blayo

DOI: 10.1371/JOURNAL.PONE.0053117

关键词: Alzheimer's diseasePathogenesisNeurotrophic factorsHippocampusOxidative stressSenile plaquesEndocrinologyAmyloidInternal medicineCholinergic neuronChemistry

摘要: Alzheimer’s disease (AD) is a neurodegenerative pathology associated with aging characterized by the presence of senile plaques and neurofibrillary tangles that finally result in synaptic neuronal loss. The major component an amyloid-β protein (Aβ). Recently, we effects single intracerebroventricular (icv) injection Aβ fragment (25–35) oligomers (oAβ25–35) for up to 3 weeks rats established clear parallel numerous relevant signs AD. To clarify long-term oAβ25–35 its potential role pathogenesis AD, determined physiological, behavioral, biochemical morphological impacts 6 after rats. was still present brain weeks. did not affect general activity temperature rhythms weeks, but decreased body weight, induced short- memory impairments, increased corticosterone plasma levels, oxidative (lipid peroxidation), mitochondrial (caspase-9 levels) reticulum stress (caspase-12 levels), astroglial microglial activation. It provoked cholinergic neuron loss brain-derived neurotrophic factor levels. cell hippocampic CA subdivisions neurogenesis. Moreover, resulted APP expression, Aβ1–42 generation, Tau phosphorylation. In conclusion, this vivo study evidenced soluble oligomeric forms short fragments Aβ, endogenously identified AD patient brains, only long-lasting pathological alterations comparable human disease, may also directly contribute progressive increase amyloid load pathology, involved physiopathology.

参考文章(87)
DG1 Standaert, VM Lee, BD Greenberg, DE Lowery, JQ Trojanowski, Molecular features of hypothalamic plaques in Alzheimer's disease. American Journal of Pathology. ,vol. 139, pp. 681- 691 ,(1991)
Tina L. Tekirian, Commentary: Aβ N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology Journal of Alzheimer's Disease. ,vol. 3, pp. 241- 248 ,(2001) , 10.3233/JAD-2001-3209
C. Lippa, L. Lannfelt, B. Ghetti, P. Gambetti, M. Tabaton, J. K. Teller, C. Russo, G. Schettini, T. C. Saido, C. Hulette, Presenilin-1 mutations in Alzheimer's disease Nature. ,vol. 405, pp. 531- 532 ,(2000) , 10.1038/35014735
Dean M. Hartley, Dominic M. Walsh, Chianping P. Ye, Thekla Diehl, Sara Vasquez, Peter M. Vassilev, David B. Teplow, Dennis. J. Selkoe, Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons The Journal of Neuroscience. ,vol. 19, pp. 8876- 8884 ,(1999) , 10.1523/JNEUROSCI.19-20-08876.1999
CJ Pike, D Burdick, AJ Walencewicz, CG Glabe, CW Cotman, Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state The Journal of Neuroscience. ,vol. 13, pp. 1676- 1687 ,(1993) , 10.1523/JNEUROSCI.13-04-01676.1993
Catherine Geci, Jonathan How, Haydar Alturaihi, Ujendra Kumar, β-Amyloid increases somatostatin expression in cultured cortical neurons Journal of Neurochemistry. ,vol. 101, pp. 664- 673 ,(2007) , 10.1111/J.1471-4159.2006.04415.X
B. Klementiev, T. Novikova, V. Novitskaya, P.S. Walmod, O. Dmytriyeva, B. Pakkenberg, V. Berezin, E. Bock, A neural cell adhesion molecule–derived peptide reduces neuropathological signs and cognitive impairment induced by Aβ25-35 Neuroscience. ,vol. 145, pp. 209- 224 ,(2007) , 10.1016/J.NEUROSCIENCE.2006.11.060
Dietmar R. Thal, Udo Rüb, Mario Orantes, Heiko Braak, Phases of Aβ-deposition in the human brain and its relevance for the development of AD Neurology. ,vol. 58, pp. 1791- 1800 ,(2002) , 10.1212/WNL.58.12.1791